In continuation of our efforts in the discovery of EGFR-2 inhibitors [46,55,56,57], we designed and synthesized a new theobromine derivative as a potential compound that may exert a marked EGFR inhibitory activity and consequently inhibit the growth of tumor cells. Here, EGFR is linked to neoplasm.